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Preclinical alterrttions of protease activities in skeletal muscles from IO-day-old dystrophic mouse, C57BL/ 
IO-mdx, were examined by using 10 fluorogenic peptide substrates. Among the activities tested, only Boc- 
Vat-Pro-Arg-MCA-hydroly~ng enzyme of the muscle microsomes howed an about 6-fold higher level of 
activity in mdx mouse. The increase in activity was not observed in tissues other than skeletal muscle. The 
enzyme had a pH optimum between 8.5 and 11 ,O, and was inhibited with DFP and variety of trypsin in- 
hibitors. The enzymatic activity transiently increased at l-2 weeks of age, the preclinical or very early stage 
of the disease. These results imply that the increased level of a trypsin-like protease possibly present in 
muscle microsomes may be closely related to the manifestation of muscular dystrophy. 
Muscular dystrophy Protease Trypsin-like enzyme Enzyme activity (mdx mouse) 
1. INTRODU~ION 
A primary cause of muscular dystrophy has not 
yet been elucidated. To demonstrate the cause of 
the disease, it is indispensable to study the bio- 
chemical changes not in the affected muscles, but 
in muscles just before the onset of the disease, 
because a variety of secondary lesions would be 
elicited by the primary lesion. It is well known that 
some muscle proteases participate in the progress 
of muscular dystrophy [l-3]. However, little or no 
information is available on the preclinical altera- 
tion of muscle protease activity. 
C57BL/lO-mdx is a recently discovered murine 
muscular dystrophy [4]. The animal is an X-linked 
recessive mutant, bearing close resemblance to 
human Duchenne muscular dystrophy on the basis 
of gene locus on each X chromosome [4]. Since the 
animal is fertile, preclinical mice, in which histo- 
logical lesion certainly begins to occur in muscles 
at 15-20 days of age 14-61, are easily obtained by 
matings of mdx homozygotes and hemizygotes. 
The feature enabled us to examine the preclinical 
alterations of muscle protease activities of the mdx 
mouse. 
Here, we present evidence for a remarkable in- 
crease in activity of Boc-Val-Pro-Arg-MCA-hy- 
drolyzing enzyme in muscle microsomes of mdx 
mouse at the age just before the onset of histo- 
logical lesion in muscles. 
2. MATERIALS AND METHODS 
The murine muscular dystrophy, CS7BL/ 1 O- 
mdx, was supplied by Dr I(. Esaki of Central In- 
stitute for Experimental Animals. Normal mice, 
C57BL/lO were obtained from Shizuoka Labora- 
tory Animal Center. 
2.2. Chemicals 
Peptidyl-4-methylcoumaryl-7-amide (MCA), 
7-amino-4-methylcoumarin (AMC), antipain, 
chymostatin, elastatinal and E-64 were purchased 
abashed by Efsevier Srienee ~blisher~ B. 1/ ~~iorn~icui revisions 
~145793/86/~3.50 0 1986 Federation of European Biochemical Societies 193 
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from the Peptide Institute. Leupeptin and bestatin 2.3. Enzyme preparation 
were gifts from Dr T. Aoyagi of the Institute of Animals were killed by decapitation. Hind-limb 
Microbial Chemistry. The other protease inhibitors muscles were imme~ately excised, washed and 
were from Sigma. homogenized in 10 vols of 0.32 M sucrose (pH 7.4) 
Table 1 
Protease activities of mitochondrial and lysosomai, microsomal, and cytosol fractions of hind-limb 
muscles from lo-day-old normal and mdx mice 
Substrate Subcellular 
PS P4 P3 P2 PI fraction 
Activity (B) 
Normal (A) mdx (B) (A) 
Boc-Val-Pro-Arg-MCA mit. & lys 
microsomes 
cytosol 
Boc-Phe-Ser-Arg-MCA mit. & lys. 
microsomes 
cytoso1 
Z-Phe-Arg-MCA mit. & lys. 
microsomes 
cytosol 
Z-Arg-Arg-MCA mit. & lys. 
microsomes 
cytosol 
Sue-Leu-Leu-Val-TV-MCA mit. & lys. 
microsomes 
cytosol 
Sue-Ala-Ala-Pro-Phe-MCA mit. & lys. 
microsomes 
cytosol 
Sue-Ala-Pro-Ala-MCA mit. & lys. 
microsomes 
cytosol 
Gly-Pro-MCA mit. & lys. 
mi~rosomes 
cytosol 
Leu-MCA mit. & tys. 
Arg-MCA mit. & lys. 
microsomes 
0.081 rt 0.014 0.171 f 0.055 
0.030 f 0.007 0.172 & 0.030 
0.341 f 0.052 0.378 & 0.079 
0.629 + 0.154 0.477 + 0.086 
0.059 f 0.004 0.063 f 0.025 
0.043 + 0.002 0.054 i 0.007 
4.23 f 0.39 5.09 zt 0.88 
0.340 f 0.007 0.290 f 0.023 
0.221 f 0.031 0.285 f 0.038 
0.595 f 0.175 0.533 + 0.070 
0.051 * 0.005 0.055 rt 0.009 
0.046 & 0.004 0.051 z!z 0.006 
0.059 f 0.010 0.071 f 0.006 
0.140 f 0.026 0.105 + 0.038 
0.046 f 0.004 0.062 2 0.016 
0.010 f 0.001 0.013 * 0.003 
0.010 f 0.001 0.015 + 0.006 
0.184 f 0.055 0.194 * 0.041 
0.012 f. 0.004 0.009 f 0.007 
0.011 f 0.003 0.016 + 0.005 
0.017 + 0.003 0.021 + 0.004 
0.658 * 0.095 0.988 f 0.163 
0.956 f 0.057 0.875 i 0.147 
0.273 + 0.043 0.324 i 0.059 
0.850 f 0.232 1.37 i 0.61 
1.43 & 0.18 1.31 f 0.39 
2.59 f 0.13 2.56 k 0.51 
0.998 f 0.144 1.13 * 0.30 
1.26 f 0.20 1.53 f 0.19 
2.79 + 0.83 2.77 f 0.41 
2.1” 
5.7b 
1.1 
0.76 
1.1 
1 .3a 
1.2 
0.85 
1.3 
0.90 
1.1 
1.1 
1.2 
0.75 
1.3 
1.3 
1.5 
1.1 
0.75 
1.5 
1.2 
l.sc 
0.92 
1.2 
1.6 
0.92 
0.99 
1.1 
1.2 
0.99 
Enzymatic activities are expressed as mean & SE nmol AMC/min per mg protein. Degree of 
significance is as follows: ‘JWO.05, bP<0.002, ‘P~0.02, mit. 6t lys., mitochondria and lysosomes; 
Boc, ~-butyloxyc~bonyl; MCA, ~methylcoum~yl-7-amide; Z, ~~zyloxycar~ny~; SW, succinyl 
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with a Teflon homogenizer in an ice bath. After 
the post-nuclear fraction (700 x g, 10 min) had 
been centrifuged at 14000 x g for 30 min, the 
supernatant was r~entrifuged at 100000 x g for 
90 min. Subcellular fractions of 14000 X g pre- 
cipitate suspended in acetate buffer (pH 5.0), 
100000 x g precipitate suspended in Tris buffer 
(pH 7.4) and 100000 x g supernatant were taken 
as the fractions of mitochondria and lysosomes, 
microsomes, and cytosol, respectively, without 
further purification. 
2.4. Enzyme assay 
The enzymatic activities were determined fluoro- 
photometric~ly using ~ptidyl-MCA as substrates 
171. The reaction mixture (0.5 ml) contains 10 FM 
peptidyl-MCA, 10 mM 2-mercaptoethanol, 50 mM 
Tris-HCl (pH 7.4), and a portion of enzyme solu- 
tion (20-50~1). After incubation at 25°C for 30-60 
min, the reaction was terminated by the addition 
of 2 ml of 0.1 M sodium acetate @H 4.3) contain- 
ing 0.1 M sodium monochloroacetate [!I]. 
2.5. Measurement of protein concentration 
Protein concentration was determined by the 
method of Lowry et al. [9] with bovine serum 
albumin as a standard. 
Table 2 
Boc-Val-Pro-Arg-MCA-hydrolyzing enzyme activities 
of microsomal fractions from various tissues of normal 
and mdx mice 
Tissue Activity (B) 
Normal (A) mdx (B) (A) 
Skeletal muscle 0.025 0.197 7.9 
Heart 0.036 0.033 0.92 
Lung 0.233 0.153 0.66 
Liver 0.020 0.016 0.80 
Kidney 0.029 0.031 1.1 
Brain 0.010 0.011 1.1 
Spleen 0.009 0.011 1.2 
Each tissue from lo-day-old normal and mdx mice (3-4 
individuals) was rinsed with physiological saline, 
homogenized and fractionated as described in the text. 
Enzymatic activities are expressed as nmol AMClmin 
per mg protein 
3. RESULTS 
3.1. Differences of protease activities between 
Norman and mdx mice at 10 days of age 
Ten peptidyl-M~A-hydroly~ng enzyme activi- 
ties of the three subcellular fractions of hind-limb 
muscle from lo-day-old normal (n= 5) and mdx 
(n =4) mice were compared with each other in 
table 1. As shown in the table, only Boc-Val-Pro- 
Arg-MCA-hydrolyzing enzyme of the microsomal 
fractions showed a markedly (dfold) higher level 
of activity in mdx mouse, while the other activities 
showed little or no significant differences between 
Table 3 
Effects of reagents on muscle microsomal Boc-VaI-Pro- 
Arg-MCA-hydrolyzing enzyme activity from IO-day-old 
mdx mouse 
Reagent Concentration % activity 
None - 100 
DFP 1 mM 0 
PMSF 1 mM 27 
EDTA 1 mM 89 
PCMB 1nlM 108 
E-64 10 ,GM 97 
Leupeptin 10 FM 48 
Antipain 10 PM 5 
Chymostatin 10 ,uM 100 
Elastatinai IOpM 100 
Bestatin 10 ,uM 101 
ST1 1 mg/ml 115 
LBTI 1 mg/ml 129 
Antithrombin III 1 unit/ml 59 
Hirudin 1 unit/ml 4 
Ovomucoid 1 mg/ml 59 
Aprotinin 1 mg/ml 49 
al-Antitrypsin 1 mglml 60 
CaCl2 fmM 104 
MgClz 1mM 104 
2-Mercaptoeth~oI 10 mM 99 
Brij 35 0.01% 119 
The enzyme was preincubated with each reagent at an in- 
dicated concentration for 30 min at 25*C, pH 7.4. 
Residual activity of the enzyme was determined by 
adding small amount of the substrate solution at a final 
concentration of 10 PM into the reaction mixture. Ab- 
breviations: DFP, diisopropyl fluorophosphate; PMSF, 
phenylmethanesulfonyl fluoride; PCMB, p-chloro- 
mercuribenzoic acid; STI, soybean trypsin inhibitor; 
LBTI, lima bean trypsin inhibitor 
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them. The marked alteration in Boc-Val-Pro-Arg- 
MCA-hydrolyzing activity of the microsomal frac- 
tion was not observed in tissues other than skeletal 
muscle (table 2). 
3.2. Enzymatic properties 
The optimum pH of the muscle enzyme from 
lo-day-old mdx mouse was between 8.5 and 11 .O. 
The enzyme was inhibited with DFP, PMSF and a 
variety of trypsin or thrombin inhibitors except 
ST1 and LBTI, but not or scarcely affected by 
PCMB, EDTA, chymostatin, elastatinal, bestatin, 
CaClz, MgClz, 2-mercaptoethanol and Brij 35 
(table 3). Thus, the enzyme is a trypsin-like or 
thrombin-like serine protease, and is active under 
the physiological pH and Ca2+ concentration. An 
apparent K, of the enzyme toward Boc-Val-Pro- 
Arg-MCA was determined to be 8.1 FM at pH 7.4. 
3.3. Boc- VaCPro-Arg-MCA-hydrolyzing enzyme 
activities in muscle microsomes from normal 
and mdx mice at different ages of the 
preclinical state 
Activities of muscle microsomal Boc-Val-Pro- 
Arg-MCA-hydrolyzing enzyme from normal and 
mdx mice were determined at different ages be- 
tween 2 and 15 days (fig. 1). The enzymatic activity 
” 
NmdX N mdx N mdx NllldX NmdX 
43 43 5 3 5 4 5 4 
2 days Jdays 7days lOdays l5days 
Fig.1. Boc-Val-Pro-Arg-MCA-hydrolyzing enzyme 
activites in muscle microsomes from normal and mdx 
mice at different ages between 2 and 15 days. The 
numbers indicated at the bottom of the columns re- 
present the number of animals tested. Open and shaded 
columns indicate normal and mdx mice, respectively. 
*Activity of the mixture of the enzyme preparation 
obtained from 3-4 individuals. **P<O.O5, ***P<O.O02. 
in mdx mouse began to significantly increase at 1 
week of age and reached a maximum value at 10 
days of age, and then reduced. These results in- 
dicate that the activity is temporally increased at 
the age just before the onset of histological esion 
in muscles [4-61. Thus, we consider that a transient 
elevation of muscle microsomal trypsin-like pro- 
tease activity may be closely associated with the oc- 
currence of murine muscular dystrophy. 
4. DISCUSSION 
We have demonstrated for the first time that the 
activity of a muscle microsomal protease, which 
hydrolyzes Boc-Val-Pro-Arg-MCA, remarkably 
increases in mdx mouse at the preclinical stage. 
Boc-Val-Pro-Arg-MCA is known as. a specific 
substrate toward thrombin [lo] and the sperm 
trypsin-like enzyme, spermosin [7]. The muscle 
protease found here is however, distinct from these 
two enzymes in susceptibilities toward inhibitors 
such as leupeptin [l l] and soybean trypsin in- 
hibitor [7]. Our enzyme is also distinct from a 
neutral protease of microsomal fractions of rat 
skeletal muscle [12] on the basis of optimum pH 
and inhibitor spectrum, suggesting the possibility 
of a novel type of protease. Alternatively, it also 
seems possible that the microsomal trypsin-like ac- 
tivity is due to tryptase of mast cells present in con- 
nective tissues of muscles, since the inhibitor spec- 
trum of the former enzyme is essentially similar to 
that of the latter enzyme [ 131. Purification and fur- 
ther characterization, as well as examination of 
localization, of the enzyme will solve this problem. 
Muscle microsomal Boc-Val-Pro-Arg-MCA- 
hydrolyzing activity elevated at the age just before 
the ctppearance of histological lesion in muscles 
[4-6~. These results prompt us to consider the 
possible participation of the enzyme in the onset of 
muscular dystrophy. The idea is not at variance 
with the result of no alteration in the enzymatic ac- 
tivity in cardiac muscle (see table 2), since histo- 
logical lesion occurs in skeletal muscle but not in 
cardiac muscle of mdx mouse by the 4th month of 
age WI. 
It is well known that the activity of cathepsin B 
and L, probably derived from invading cells such 
as macrophages, increases in muscular tissues from 
the early stage of muscular dystrophy [ 1,2,14]. We 
also confirmed this phenomenon in mdx mouse 
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after 20 days of age (unpublished), indicating that 
the activity increase of our enzyme precedes the oc- 
currence of elevation of cathepsin B and L activity. 
In addition, our prelimin~ ex~~ment showed 
that there is also a preclinical alteration in the 
microsomal trypsin-like activity in one-third or a 
half of mdx heterozygotes. Both of these results 
further support the above assumption that the 
microsomal protease may be involved in the early 
event or primary cause, rather than the secondary 
consequences, of muscular dystrophy, though the 
present data have not yet been documented con- 
vincingly. 
It has been reported that the administration of 
leupeptin to the dystrop~c mouse, C57BL/6J 
(d~‘/dy2’), before the onset of muscle weakness 
inhibits the appearance of clinical signs of weak- 
ness as well as those of histological lesion [IS]. 
These findings may imply the involvement of a 
putative trypsin-like protease in the manifestation 
of muscular dystrophy. 
Further studies on the effects of trypsin in- 
hibitors on the onset of muscular dystrophy in mdx 
mouse will clearly demonstrate the patho-physiolo- 
gical role of the enzyme. 
ACKNOWLEDGEMENTS 
This work was supported in part by research 
grants for intractable disease and for muscular 
dystrophy from the Ministry of Health and Welfare 
of Japan. 
REFERENCES 
[l] Pennington, R.J.T. (1977) in: Proteinases inMam- 
malian Cells and Tissues (Barrett, A.J. ed.) pp. 
515-543, Noah-HoIl~d, Amsterdam, New York, 
Oxford. 
[21 Kar, N.C. and Pearson, C.M. (1978) Muscle Nerve 
1, 308-313. 
[3] Sugita, H., Ishiura, S., Nonaka, I. and Hanada, K. 
(1983) in: Muscular Dystrophy (Ebashi, S. and 
Ozawa, E. eds) pp. 229-236, Japan Sci. Sot. Press, 
Tokyo; Springer, Berlin. 
141 Bulfield, G., Siller, W.G., Wight, P.A.L. and 
Moore, K.J. (1984) Proc. Natl. Acad. Sci. USA 81, 
1189-l 192. 
151 Dangain, J. and Vrbova, G. (1984) Muscle Nerve 7, 
700-704. 
[61 Tanabe, Y,, Esaki, K. and Nomura, T. (1986) Acta 
r71 
[81 
[91 
1101 
I111 
[I21 
1131 
1141 
1151 
Neuropathol., in press. 
Sawada, H., Yokosawa, H. and Isbii, S. (1984) J. 
BioI. Chem. 259, 2900-2904. 
Barrett, A.J. and Kirschke, H. (1981) Methods 
Enzymol. 80, 535-561. 
Lowry, O.H., Rosebrough, N.J., Farr, A.L. and 
Randall, R.J. (1951) J. Biol. Chem. 193, 265-275. 
Morita, T., Kato, H., Iwanaga, S., Takada, K., 
Kimura, T. and Sakakibara, S. (1977) J. Biochem. 
82, 1495-1498. 
Aoyagi, T. and Umezawa, H. (1975) in: Protein- 
ases and Biological Control (Reich, E., Rifkin, 
D.B. and Shaw, E. eds) pp. 429-454, Cold Spring 
Harbor Laboraty, Cold Spring Harbor, NY. 
Takahashi, K., Ichihara, Y. and Sogawa, K. (1983) 
in: Muscular Dystrophy (Ebashi, S. and Ozawa, E. 
eds) pp. 237-245, Japan. Sci. Sot. Press, Tokyo; 
Springer, Berlin. 
Smith, T. J., Hougland, M. W. and Johnson, D.A. 
(1984) J. Biol. Chem. 259, 11046-11051. 
Kominami, E., Bando, Y. ii, Hizawa, K. and 
Katunuma, N. (1984) J. Biochem. 96, 1841-1848. 
Sher, J.H., Stracher, A., Shafiq, S.A. and Hardy- 
Stashin, J. (1981) Proc. Natl. Acad. Sci. USA 78, 
7742-7744. 
197 
